<PAGE>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   FORM 10-QSB

(Mark One)

( X )    QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
         ACT OF 1934

For the quarterly period ended:                      March 31, 1997
                                          -------------------------------

(  )     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from:                                to

Commission file number:                                       0-13265

                          UCI MEDICAL AFFILIATES, INC,
        (Exact name of small business issuer as specified in its charter)

              Delaware                               59-2225346
  (State or other jurisdiction             (IRS Employer Identification No.)
of incorporation or organization)

                 1901 Main Street, 12th Floor, Mail Code 1105,
                         Columbia, SC 29201 (Address of
                          principal executive offices)

                                 (803) 252-3661
                           (Issuer's telephone number)


       (Former name, address or fiscal year, if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. ( X )YES ( ) NO


                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13, or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court. ( )YES ( ) NO


                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

       4,807,803 shares of $.05 common stock outstanding at March 31, 1997

   Transitional Small Business Disclosure Format (check one): ( )YES ( X ) NO



                                       1
<PAGE>


                          UCI MEDICAL AFFILIATES, INC.

                                      INDEX


<TABLE>
<CAPTION>


                                                                                                  PAGE
                                                                                                 NUMBER

PART I            FINANCIAL INFORMATION
<S>                                      <C> <C>                                                  <C>

                  Item 1   Financial Statements

                           Consolidated Balance Sheets - March 31, 1997
                           and September 30, 1996                                                      3

                           Consolidated Statements of Operations for the quarters and
                           the six months ending March 31, 1997 and March 31, 1996                     4

                           Consolidated Statements of Cash Flows for the six months
                           ending March 31, 1997 and March 31, 1996                                    5

                           Notes to Consolidated Financial Statements                                  6

                  Item 2   Management's Discussion and Analysis of Financial
                           Condition and Results of Operations                                     7 - 9


PART II           OTHER INFORMATION

                  Items 1-6                                                                           10


SIGNATURES                                                                                            11
</TABLE>





                                       2
<PAGE>



                          UCI Medical Affiliates, Inc.

                           Consolidated Balance Sheets


<TABLE>
<CAPTION>


                                                               MARCH 31, 1997   SEPTEMBER 30, 1996
                                                              ----------------  ------------------
                                                                 (UNAUDITED)      (AUDITED)
<S>                                                            <C>             <C>
ASSETS
Current assets
   Cash and cash equivalents                                   $    168,390    $    237,684

   Accounts receivable, less allowance for doubtful accounts
       of $877,741 and $1,021,856                                 5,182,353       4,187,394

   Inventory                                                        407,379         407,617

   Deferred taxes                                                   197,056         197,056

   Prepaid expenses and other current assets                        585,366         441,384

                                                               ------------    ------------
Total current assets                                              6,540,544       5,471,135


Property and equipment, less accumulated depreciation of
   $2,376,388 and $2,025,970                                      3,440,517       3,300,048

Deferred taxes                                                    1,205,126         855,126

Excess of cost over fair value of assets acquired, less
   accumulated amortization of $1,424,175 and $1,210,569          5,741,814       5,828,963

Other assets                                                        274,707         277,422
                                                               ------------    ------------

Total Assets                                                   $ 17,202,708    $ 15,732,694
                                                               ============    ============

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
   Current portion of long-term debt                           $    942,472    $    913,749

   Accounts payable                                               1,258,637       1,391,858

   Accrued salaries and payroll taxes                               780,269         750,745

   Other accrued liabilities                                        344,496         394,635
                                                               ------------    ------------
Total current liabilities                                         3,325,874       3,450,987


Long-term debt, net of current portion                            5,832,918       4,459,484

                                                               ------------    ------------
Total Liabilities                                                 9,158,792       7,910,471

                                                               ------------    ------------

Commitments and contingencies                                             0               0


Stockholders' Equity
   Preferred stock, par value $.01 per share:
      Authorized shares - 10,000,000; none issued                         0               0

   Common stock, par value $.05 per share:
      Authorized shares - 10,000,000
      Issued and outstanding- 4,807,803 and 4,807,807
         shares                                                     240,390         240,390

   Paid-in capital                                               13,732,393      13,732,393
   Accumulated deficit                                           (5,928,867)     (6,150,560)
                                                               ------------    ------------
Total Stockholders' Equity                                        8,043,916       7,822,223
                                                               ------------    ------------

Total Liabilities and Stockholders' Equity                     $ 17,202,708    $ 15,732,694
                                                               ============    ============

</TABLE>

                 See Notes to Consolidated Financial Statements.



                                       3
<PAGE>



                          UCI Medical Affiliates, Inc.

                      Consolidated Statements of Operations
                                   (unaudited)

<TABLE>
<CAPTION>


                                                 Three Months Ended March 31,     Six Months Ended March 31,
                                                   1997              1996            1997            1996
                                               -------------    --------------  ------------    --------------
<S>                                             <C>             <C>             <C>             <C>         
Revenues                                        $  6,714,653    $  5,909,220    $ 13,202,561    $ 11,069,503
Operating costs                                    6,145,402       5,346,241      12,275,634       9,999,069
                                                ------------    ------------    ------------    ------------
Operating margin                                     569,251         562,979         926,927       1,070,434

General and administrative expenses                   52,194          43,841          89,903          62,237
Depreciation and amortization                        296,842         229,258         586,317         433,815
                                                ------------    ------------    ------------    ------------
Income (loss) from operations                        220,215         289,880         250,707         574,382

Other income (expense)
   Interest expense, net of interest income         (189,766)       (137,456)       (356,560)       (288,953)
   Gain (loss) on disposal of equipment               (5,219)            778          (5,219)          2,105
                                                ------------    ------------    ------------    ------------
Other income (expense)                              (194,985)       (136,678)       (361,779)       (286,848)

Income (loss) before benefit (provision )for
   income taxes                                       25,230         153,202        (111,072)        287,534
Benefit (provision )for income taxes                 166,383               0         332,765               0
                                                ------------    ------------    ------------    ------------

Net income (loss)                               $    191,613    $    153,202    $    221,693    $    287,534
                                                ============    ============    ============    ============


Net income (loss) per common equivalent share   $        .04    $        .04    $        .05    $        .07
                                                ============    ============    ============    ============

Weighted average common shares
   outstanding                                     4,807,807       4,154,734       4,807,807       3,932,259
                                                ============    ============    ============    ============

</TABLE>

                 See Notes to Consolidated Financial Statements.




                                       4
<PAGE>



                          UCI Medical Affiliates, Inc.

                      Consolidated Statements of Cash Flows

                                   (unaudited)


<TABLE>
<CAPTION>


                                                           Six Months Ended March 31,
                                                                1997          1996
                                                           -----------    -----------
<S>                                                        <C>            <C>        
OPERATING ACTIVITIES:
Net income (loss)                                          $   221,693    $   287,534
Adjustments to reconcile net income (loss) to net
   cash provided by  (used-in) operating activities:
      (Gain) loss on disposal of equipment                       5,219         (2,105)
      Provision for losses on accounts receivable              266,080        367,097
      Depreciation and amortization                            586,317        433,815
      Deferred taxes                                          (350,000)             0

Changes in operating assets and liabilities:
   (Increase) decrease in accounts receivable               (1,261,039)    (1,088,157)
   (Increase) decrease in inventories                              238         (2,288)
   (Increase) decrease in prepaid expenses and other
      current assets                                          (143,982)      (145,348)
   Increase (decrease) in accounts payable and accrued
      expenses                                                (153,836)      (654,614)
                                                           -----------    -----------

Cash provided by (used in) operating activities               (829,310)      (804,066)
                                                           -----------    -----------

INVESTING ACTIVITIES:
Purchases of property and equipment                           (275,875)      (243,033)
Acquisitions of goodwill                                       (26,551)      (139,450)
(Increase) decrease in other assets                              2,715        (19,286)
                                                           -----------    -----------


Cash provided by (used in) investing activities               (299,711)      (401,769)
                                                           -----------    -----------

FINANCING ACTIVITIES:
Issuance of common stock, net of redemptions                         0      1,500,492
Net borrowings (payments) under line-of-credit agreement     1,935,396        250,000
Increase in long-term debt                                     280,000              0
Payments on long-term debt                                  (1,155,669)      (447,010)
                                                           -----------    -----------

Cash provided by (used in) financing activities              1,059,727      1,303,482
                                                           -----------    -----------

Increase (decrease) in cash and cash equivalents               (69,294)        97,647
Cash and cash equivalents at beginning of period               237,684         76,513
                                                           -----------    -----------

Cash and cash equivalents at end of period                 $   168,390    $   174,160
                                                           ===========    ===========
</TABLE>

                 See Notes to Consolidated Financial Statements


                                       5
<PAGE>


                          UCI MEDICAL AFFILIATES, INC.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)



BASIS OF PRESENTATION:

The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-QSB and Article 10 of
Regulation S-X of the Securities and Exchange Commission. Accordingly, they do
not include all of the information and footnotes required by generally accepted
accounting principles for complete financial statements. In the opinion of
management, all adjustments (consisting only of those of a normal recurring
nature) considered necessary for a fair presentation have been included.
Operating results for the six month or three month periods ended March 31, 1997
are not necessarily indicative of the results that may be expected for the
fiscal year ending September 30, 1997. For further information, refer to the
audited consolidated financial statements and footnotes thereto included in the
Company's annual report on Form 10-KSB for the year ended September 30, 1996.

The consolidated financial statements of UCI Medical Affiliates, Inc. include
the accounts of UCI Medical Affiliates, Inc. ("UCI"), its wholly owned
subsidiary, UCI Medical Affiliates of SC, Inc. ("UCI-SC") and Doctor's Care, PA
("the P.A."), collectively the "Company". The financial statements of the P.A.
are consolidated with UCI because UCI-SC has unilateral control over the assets
and operations of the P.A. and, notwithstanding the lack of technical majority
ownership, consolidation of the P.A. with UCI is necessary to present fairly the
financial position and results of operations of UCI. UCI-SC provides non-medical
management and administrative functions for 30 medical centers, operating as
Doctor's Care (the "Centers"). All medical services at the Centers are provided
by or under the supervision of the P.A., which has contracted with UCI-SC to
provide the medical direction of the Centers. The medical directors operate the
Centers under the financial and operational control of UCI-SC. However, medical
supervision of the centers is provided solely by the P.A. The P.A. remits to
UCI-SC all medical service revenues generated by the Centers, net of expenses
incurred by the P.A. This compensation is recorded in the accompanying financial
statements as revenue. Control of the P.A. is perpetual and other than temporary
because of the nature of this relationship and the management agreements between
the entities. The net assets of the P.A. are not material for any period
presented and intercompany accounts and transactions have been eliminated.


EARNINGS PER SHARE

The computation of income per common and common equivalent share is based on the
weighted average number of common shares outstanding during the period plus (in
periods in which they have a dilutive effect) the effect of common shares
issuable from stock options, using the treasury stock method.



                                       6
<PAGE>


                                     PART I

                              FINANCIAL INFORMATION

                                     ITEM 2



MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS

The following discussion and analysis provides information which the Company
believes is relevant to an assessment and understanding of the Company's
consolidated results of operations and financial condition. This discussion
should be read in conjunction with the consolidated financial statements and
notes thereto.

The consolidated financial statements of UCI Medical Affiliates, Inc. include
the accounts of UCI Medical Affiliates, Inc. ("UCI"), its wholly owned
subsidiary, UCI Medical Affiliates of South Carolina, Inc. ("UCI-SC") and
Doctor's Care, PA ("the P.A."), collectively the "Company". The financial
statements of the P.A. are consolidated with UCI because UCI-SC has unilateral
control over the assets and operations of the P.A. and, notwithstanding the lack
of technical majority ownership, consolidation of the P.A. with UCI is necessary
to present fairly the financial position and results of operations of UCI. The
management agreement between UCI-SC and the P.A. conveys to the Company
perpetual, unilateral control over the assets and operations of the P.A. Control
is perpetual rather than temporary because of (i) the length of the term of the
agreement, (ii) the continuing investment of capital by the Company, (iii) the
employment of all of the non-physician personnel by UCI-SC and (iv) the nature
of the services provided to the P.A. by UCI-SC.

Procedurally, the management agreement calls for the P.A. to provide medical
services and charge a fee to the patient or to the patient's insurance carrier
or employer for such services. Physician salaries are paid out of these revenues
and all remaining revenues are passed to UCI-SC as a management fee. UCI-SC
provides all support personnel (nurses, technicians, receptionists), all
administrative functions (billing, collecting, vendor payment), and all
facilities, supplies and equipment. The consolidated accounts of the Company
include all revenue and all expenses (including physician salaries) of all three
entities.

The P.A. enters into employment agreements with physicians for terms ranging
from one to ten years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license. Over 80% of the physicians employed by the P.A. are paid on an
hourly basis for time scheduled and worked at the medical centers. The other
physicians are salaried. A few of the physicians have incentive compensation
arrangements, however, no amounts were accrued or paid during the Company's
three prior fiscal years that were significant.

RESULTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 1997 AS COMPARED TO THE THREE MONTHS ENDED
MARCH 31, 1996

Revenues of $6,715,000 for the quarter ending March 31, 1997 reflect an increase
of 14% from those of the quarter ending March 31, 1996.

This increase in revenue is attributable to a number of factors. The Company
engaged in a significant expansion, increasing the number of medical centers
from 26 to 30. This expansion included Columbia's Doctor's Care-Wateree added in
June 1996; Beaufort's Doctor's Care-Beaufort added in July 1996; Greenville's
Doctor's Care-Simpsonville added in October 1996; and Aiken's Doctor's
Care-Aiken added in October 1996. Of the $806,000 in revenue growth from the
second quarter of fiscal 1996 to the second quarter of fiscal 1997,
approximately $545,000 was from the four locations opened after March 31, 1996.

The Company has increased its services provided to members of Health Maintenance
Organizations (HMOs). In such arrangements, the Company, through Doctor's Care,
P.A., acts as the designated primary caregiver for members of the HMO who have
selected Doctor's Care as their primary care provider. The Company began
participating in an HMO operated by Companion HealthCare Corporation
("Companion"), a wholly owned subsidiary of Blue Cross Blue Shield of South
Carolina. 



                                       7
<PAGE>


The Company now acts as primary care provider for four HMOs, including
Companion and is the primary care "gatekeeper" for approximately 20,000
capitated lives. While HMOs do not, at this time, have a significant penetration
into the South Carolina market, the Company believes that HMOs and other managed
care plans will experience a substantial increase in market share in the next
few years, and the Company is therefore positioning itself for that possibility.
Capitated revenue grew from approximately $599,000 in the second quarter of
fiscal 1996 to approximately $708,000 in the second quarter of fiscal 1997.

The Company negotiates contracts with HMOs for the P.A.'s physicians to provide
health care on a capitated reimbursement basis. Under these contracts, which
typically are automatically renewed on an annual basis, the P.A. physicians
provide virtually all covered primary care services and receive a fixed monthly
capitation payment from the HMOs for each member who chooses a P.A. physician as
his or her primary care physician. The capitation amount is fixed depending upon
the age and sex of the HMO enrollee. Contracts with HMOs accounted for
approximately 11% of the Company's net revenue in the second quarter of fiscal
1997.

To the extent that enrollees require more care than is anticipated, aggregate
capitation payments may be insufficient to cover the costs associated with the
treatment of enrollees. Higher capitation rates are typically received for
senior patients because their medical needs are generally greater and
consequently the cost of covered care is higher.

Increased revenues also reflect the Company's heightened focus on occupational
medicine and industrial health services. Focused marketing materials, including
quarterly newsletters for employers, were developed to spotlight the Company's
services for industry. Additionally, the Company has an agreement with Companion
Property and Casualty Insurance Company, wherein the Company acts as the primary
care provider for injured workers of firms insured through Companion Property
and Casualty Insurance Company. Companion Property and Casualty Insurance
Company is wholly owned by Blue Cross Blue Shield of South Carolina and is a
primary shareholder of the Company.

Patient encounters increased to 95,000 in the second quarter of fiscal 1997 from
86,000 in the second quarter of fiscal 1996.

Even with the positive effects of the factors mentioned above, revenues were
short of goals for the quarter, due in part to the increased competition from
hospitals and other providers in Columbia, Greenville, Sumter and Myrtle Beach.
In each of these areas, regional hospitals have acquired or opened new primary
care physician practices that compete directly with the Company for patients. In
each case, the hospital owners of our competition is believed to have
significantly greater resources than the Company. Management believes that such
competition will continue into the future and plans to compete on a basis of
quality service and accessibility.

An operating margin of $569,000 was earned during the second quarter of fiscal
1997 as compared to an operating margin of $563,000 realized for the second
quarter of fiscal 1996. Management believes that lack of improvement in the
margin is mainly the result of some start-up costs being absorbed for the
locations added since March 1996.

Depreciation and amortization expense increased to $297,000 in the second
quarter of fiscal 1997, up from $229,000 in the second quarter of fiscal 1996.
This increase reflects higher depreciation expense as a result of significant
leasehold improvements and equipment upgrades at a number of the Company's
medical centers, as well as an increase in amortization expense related to the
intangible assets acquired from the Company's purchases of existing practices as
noted above. Interest expense increased from $137,000 in the second quarter of
fiscal 1996 to $190,000 in the second quarter of fiscal 1997 primarily as a
result of the interest costs associated with the indebtedness incurred in the
Company's purchase of these assets and centers.

Effective October 1, 1993, the Company adopted Statement of Financial Standards
No. 109, "Accounting for Income Taxes" ("SFAS 109") which requires the use of an
asset and liability approach to accounting for income taxes. The effect of
adopting SFAS 109 was to reduce income tax expense for the second quarter of
fiscal 1997 by $175,000. As part of the adoption of SFAS 109, the Company has
recognized a deferred tax asset relating to net operating loss carry forwards
which are available to offset future taxable income.




                                       8
<PAGE>


In determining that it was more likely than not that the recorded deferred tax
asset would be realized, management of the Company considered the following:

o      The budgets and forecasts that management and the Board of Directors had
       adopted for the next five fiscal years including plans for expansion.

o      The ability to utilize NOL's prior to their expiration.

o      The potential limitation of NOL utilization in the event of a change in
       ownership.

o      The generation of future taxable income in excess of income reported on
       the consolidated financial statements.

FOR THE SIX MONTHS ENDED MARCH 31, 1997 AS COMPARED TO THE SIX MONTHS ENDED
MARCH 31, 1996

Revenues of $13,203,000 reflect an increase of 19% from the same period in
fiscal 1996 and is attributable to the expansion, marketing and line of business
factors discussed above. Patient encounters increased to 191,000 for the six
months ended March 31, 1997 from 165,000 for the six months ended March 31,
1996.

FINANCIAL CONDITION AT MARCH 31, 1997

Cash and cash equivalents decreased by $70,000 during the six months ended March
31, 1997 and were utilized mainly for working capital needs and to fund the
expansion previously discussed.

Accounts receivable increased 24% during the period, reflecting the addition of
the new centers and the overall growth in patient visits to existing centers.

The increase in goodwill attributable to the purchases of the four practices
noted above was offset by the amortization recorded.

Long-term debt increased from $4,459,000 at September 30, 1996 to $5,833,000 at
March 31, 1997 primarily as a result of indebtedness incurred in capital leases
for Center upfits, and in the utilization of an operating line of credit.
Management believes that it will be able to fund debt service requirements out
of cash generated through operations.

Overall, the Company's current assets exceeded its current liabilities at March
31, 1997 by $3,215,000.

LIQUIDITY AND CAPITAL RESOURCES

The Company requires capital principally to fund growth (acquire new centers),
for working capital needs and for the retirement of indebtedness. The Company's
capital requirements and working capital needs have been funded through a
combination of external financing (including bank debt and proceeds from the
sale of common stock to Companion HealthCare Corporation and Companion Property
and Casualty Insurance Company), internally generated funds and credit extended
by suppliers.

Operating activities used $829,000 of cash during the six months ended March 31,
1997. This reflects growth in the Company's accounts receivable as well as
prepaid expenses and a decrease in accounts payable and accrued expenses. The
growth in accounts receivable is the result of growth in the number of Centers,
patient visits and charges per patient visit.

Investing activities used $300,000 of cash during the period as a result of
expansion efforts. Continued growth is anticipated during the remainder of
fiscal 1997.

The Company entered into a long-term debt agreement with its primary lender in
November 1996 for a $3,000,000 line of credit bearing interest at an annual rate
of prime plus one (1%) percent. Proceeds from this line of credit were used to
pay off existing debt of $1,475,000.



                                       9
<PAGE>


                                     PART II

                                OTHER INFORMATION



Item 1            LEGAL PROCEEDINGS

                  The Company is not a party to any pending litigation other
                  than routine litigation incidental to the business or that
                  which is immaterial in amount of damages sought.


Item 2            CHANGES IN SECURITIES

                  This item is not applicable.


Item 3            DEFAULTS UPON SENIOR SECURITIES

                  This item is not applicable.


Item 4            SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

                  This item is not applicable.


Item 5            OTHER INFORMATION

                  This item is not applicable.


Item 6            EXHIBITS AND REPORTS ON FORM 8-K

                  The Financial Data Schedule is included herein as Exhibit 27.




                                       10
<PAGE>


                                    SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


UCI Medical Affiliates, Inc.
         (Registrant)



/S/ M.F. MCFARLAND, III, M.D.           /S/ JERRY F. WELLS, JR.
Marion F. McFarland, III, M.D.          Jerry F. Wells, Jr.
President, Chief Executive Officer,     Executive Vice President of Finance and
and Chairman of the Board               Chief Financial Officer




Date:  April 17, 1997




                                       11
<PAGE>